407P Pembrolizumab Expanded Access Program (EAP) in Taiwan for patients with progressive advanced melanoma after prior ipilimumab treatment. (20th December 2016) - Yang, C-K.; Liu, J-H.; Lin, C-C.; Liu, T-C.; Cheng, P-T.; Lin, C-Y.; Hu, H-T.; Cao, C-R.; Huang, W-T.; Chen, L-P.; Chang, W-C.